The name “VENN” is inspired by the Venn diagram. Our brand identity is rooted at the intersection of science, nature, and modern life. When defining who we are, we visualized a Venn diagram—each circle representing a core pillar of our philosophy—with VENN positioned where all three converge.

VENN is built around the “engine” of skincare—advanced technologies that optimize and deliver key nutrients and high-performance natural ingredients deep into the skin. While ingredients matter, it’s the synergy between potent actives and cutting-edge delivery systems that drives transformative results. Our formulations leverage South Korea’s most advanced ingredient optimization and delivery technologies to achieve visible, clinically proven outcomes.

You can view our Terms of Service and Privacy Policy for more information.

Yes. VENN is certified by Leaping Bunny and is 100% cruelty-free. We do not test on animals, nor do we use ingredients that have been tested on animals.

Yes. VENN is a clean beauty brand. While definitions of “clean” may vary, our standard is uncompromising. We exclude ingredients that are controversial or linked to potential health risks. VENN does not use parabens, silicones, phthalates, mineral oil, synthetic colorants, sulfates (SLS/SLES), PEGs, phenoxyethanol, coal tar, or any ingredients we consider potentially harmful or unsafe.

Yes. The efficacy of our products is validated through third-party human clinical trials. In the U.S., studies were conducted in accordance with ICH Guideline E6 for Good Clinical Practice, 21 CFR Parts 50 and 56, and applicable regulatory standards. In South Korea, studies followed the Ministry of Food and Drug Safety’s guidelines for cosmetic efficacy testing and the respective testing facility’s Standard Operating Procedures.

Recommended Daily Ritual (Morning & Evening):

1. Cleanse: Moisture-Balance All-In-One Face Cleanser
2. Tone + Balance: Synbiotic Defense Mist
3. Regenerate + Rejuvenate: Regenerative 10B-EXO EGF Ampoule
4. Prevent + Boost: Age-Response Compound K Hyaluronic Booster and/or Probiotics Cica Complex Biome Booster
5. Correct + Moisturize (Face): Age-Reversing All-In-One Concentrate or Vitamin B Activated All-In-One Concentrate
6. Correct + Moisturize (Eye Area): Age-Recharge Compound K Eye Concentrate
7. Correct + Moisturize (Lips): Advanced Regenerative Hyaluronic Lip Serum
8. Protect + Nourish: Advanced Multi-Perfecting Red Oil Serum
9. (Morning Only): Finish with your preferred SPF

Recommended Two to Three Times Weekly:

• Exfoliate + Revitalize: Collagen Intensive Phyto-Retinol Resurfacing Mask
• Prevent + Boost: Collagen Intensive Phyto-Retinol Renewal Mask
• Renew + Correct: Retinal Infusion MLV10 Serum
• Protect + Nourish: Concentrated Revitalizing Lifting Mask

Both are multi-correctional moisturizing creams formulated to deliver comprehensive skincare benefits:

• Age-Reversing All-In-One Concentrate: Targets visible signs of aging with Ginsenoside Compound K, clinical-grade peptides, and antioxidants. Provides 24-hour hydration, improves elasticity, reduces the appearance of wrinkles, brightens, and refines skin texture.
• Vitamin B Activated All-In-One Concentrate: Focuses on repair and barrier support, powered by six B vitamins, eleven amino acids, and solubilized mastic gum. Offers 24-hour hydration, enhances firmness, and improves tone and texture.

You may choose one based on your skin’s needs or alternate between the two for morning and evening use.

For a simplified regimen, we recommend either the Age-Reversing or Vitamin B Activated All-In-One Concentrate. Each delivers hydration, firming, brightening, and anti-aging benefits in a single step.

Yes. All VENN products are suitable for all skin types and are dermatologist-tested to be non-irritating and non-sensitizing.

Yes. VENN products are well-suited for acne-prone skin. We especially recommend the Synbiotic Defense Mist and Probiotics Cica Complex Biome Booster, both of which help balance sebum production and feature non-comedogenic, anti-inflammatory ingredients.

Retinoids and salicylic acid are two ingredients commonly avoided during pregnancy and breastfeeding. The following VENN products contain these ingredients. As individual needs vary, we recommend consulting your physician for personalized guidance:

• Salicylic Acid (and derivatives): Present in Synbiotic Polyamine Shampoo.
• Retinoids:
  • Retinal (Retinaldehyde): Found in Age-Recharge Compound K Eye Concentrate (0.02%) and Retinal Infusion MLV10 Serum (0.1%), both utilizing multi-lamellar liposome delivery. These should be avoided during pregnancy and nursing per dermatological guidance.
  • Bakuchiol: A plant-based retinol alternative used in the Collagen Intensive Phyto-Retinol Renewal Mask, Resurfacing Mask, and Retinal Infusion MLV10 Serum. Bakuchiol provides similar benefits to retinol without the associated risks and is generally considered safe during pregnancy and breastfeeding.

VENN uses safe and effective preservative systems, including 1,2-Hexanediol, Scutellaria Baicalensis Root Extract, and Paeonia Suffruticosa Root Extract.

Store VENN products at room temperature, away from direct sunlight and frequent temperature changes. For a cooling application, the Collagen Intensive Phyto-Retinol Renewal Mask may be refrigerated.

No. Ginsenoside Compound K is compatible with both Vitamin C and Retinol/Retinal. It is well-tolerated and can be safely integrated into routines that include these actives. As always, we recommend patch testing and gradually introducing new products.

The color in these formulas comes from fermented root extracts, including Lithospermum Erythrorhizon and Angelica Gigas. While light exposure may cause fading over time, this does not affect product performance.

Yes. VENN products are compatible with Vitamin C and Retinol/Retinal. Apply your Vitamin C and/or Retinol first, allow it to fully absorb, then follow with your VENN products.

• Immediate skin moisture content improvement study of 25 participants using Corneometer (statistically significant, p<0.001).
• Make-up cleansing efficacy study of 25 participants using Chromameter (statistically significant, p<0.001).
• Pore and wrinkle cleansing efficacy study of 25 participants using Chromameter and Folliscope (statistically significant, p<0.001).
  
  
• Dry scale relieving efficacy (exfoliation) study of 25 participants using Corneofix and Visioscan (statistically significant, p<0.001).

• 24-hour hydration study of 22 participants with readings at baseline, 3, 6 and 24 hours using Corneometer (statistically significant, p<0.001).

• Skin tone evenness study of 26 participants with readings at baseline and immediately after use using VISIA CR and Image-pro Plus (statistically significant, p<0.05).

• Skin scale study of 26 participants with readings at baseline and immediately after use using D-squame disc and SquameScan (statistically significant, p<0.05).

• Skin pore study of 26 participants with readings at baseline and immediately after use using ANTERNA 3D CS (statistically significant, p<0.05).

• Anti-wrinkle study of 26 participants with readings at baseline and immediately after use using PRIMOS CR (statistically significant, p<0.05).

• Skin texture study of 26 participants with readings at baseline and immediately after use using PRIMOS CR (statistically significant, p<0.05).

• Consumer perception study of 26 participants with self assessment at immediately after use.

• 2-week skin hydration study of 21 participants with readings at baseline and week 2 using Corneometer CM825 (statistically significant, p<0.05).

• 2-week wrinkles and crow's feet study of 21 participants with readings at baseline and week 2 using Antera 3D CS (statistically significant, p<0.05).

• 2-week skin texture study of 21 participants with readings at baseline and week 2 using Antera 3D CS (statistically significant, p<0.05).

• 2-week pore size study of 21 participants with readings at baseline and week 2 using Antera 3D CS (statistically significant, p<0.05).

• 2-week pigmentation (melasma, dark spots, and freckles) study of 21 participants with readings at baseline and week 2 using Antera 3D CS (statistically significant, p<0.05).

• 2-week consumer perception study of 21 participants with self assessment at week 2.

• 2-week surface elasticity study of 23 participants with readings at baseline and week 2 using Cutometer MPA580 2mm probe (statistically significant, p<0.05).

• 2-week deep skin elasticity study of 23 participants with readings at baseline and week 2 using Cutometer MPA580 8mm probe (statistically significant, p<0.05).

• 2-week cheek lifting study of 23 participants with readings at baseline and week 2 using F-ray → Image-pro® plus (statistically significant, p<0.05).

• 2-week jawline lifting study of 23 participants with readings at baseline and week 2 using F-ray → Image-pro® plus (statistically significant, p<0.05).

• 2-week nasolabial fold lifting study of 23 participants with readings at baseline and week 2 using Antera 3D CS → Image-pro® plus (statistically significant, p<0.05).

• 2-week lifting at the corners of the mouth study of 23 participants with readings at baseline and week 2 using F-ray → Image-pro® plus (statistically significant, p<0.05).

• 2-week wrinkles and crow’s feet study of 23 participants with readings at baseline and week 2 using Antera 3D CS (statistically significant, p<0.05).

• 2-week soothing of skin damaged by external stimulation (physical) study of 23 participants with readings at baseline and week 2 using Antera 3D CS → Image-pro® plus (statistically significant, p<0.05).

• 2-week soothing of skin damaged by external stimulation (chemical) study of 23 participants with readings at baseline and week 2 using Antera 3D CS → Image-pro® plus (statistically significant, p<0.05).

• 2-week soothing of skin damaged by external stimulation (UV exposure) study of 23 participants with readings at baseline and week 2 using Antera 3D CS → Image-pro® plus (statistically significant, p<0.05).

• 2-week surface melasma study of 23 participants with readings at baseline and week 2 using Antera 3D CS (statistically significant, p<0.05).

• 2-week inner melasma study of 23 participants with readings at baseline and week 2 using VISIA CR → Image-pro® plus (statistically significant, p<0.05).

• In-vitro study on intracellular collagen synthesis assay, evaluating the cell survival rate in Normal Human Dermal Fibroblast (NHDF), evaluating the collagen production in Normal Human Dermal Fibroblast (NHDF) (quantification of PIP), and measuring collagen fiber production image in Normal Human Dermal Fibroblast (NHDF).

• In-vitro study on would healing, evaluating the cell survival rate in Human Epidermal Keratinocytes (HaCaT) and measuring and analyzing wound healing images in Human Epidermal Keratinocytes (HaCaT).

• 2-week consumer perception study of 21 participants with self assessment at week 2.

• 8-week trans-epidermal water loss study of 28 participants with readings at baseline, 2, 4 and 8 weeks using Tewameter (statistically significant, p<0.05).

• 8-week dermal density study of 28 participants with readings at baseline, 2, 4 and 8 weeks using Dermascan (statistically significant, p<0.05).

• 8-week skin elasticity study of 28 participants with readings at baseline, 2, 4 and 8 weeks using Cutometer (statistically significant, p<0.05).

• 8-week anti-wrinkle study of 28 participants with readings at baseline, 2, 4 and 8 weeks using PRIMOS (statistically significant, p<0.05).

• 8-week skin brightness study of 28 participants with readings at baseline, 2, 4 and 8 weeks using Spectrophotometer (statistically significant, p<0.05).

• 8-week skin pore study of 28 participants with readings at baseline, 2, 4 and 8 weeks using ANTERA 3D (statistically significant, p<0.05).

• 2-week consumer perception study of 40 participants with self assessment at week 2.

• 4-week triple lifting study (eye, mouth and cheek areas) of 21 participants with readings at baseline, 2 and 4 weeks using VISIA and Antera 3D (statistically significant, p<0.05).

• 4-week skin elasticity study of 21 participants with readings at baseline, 2 and 4 weeks using Cutometer (statistically significant, p<0.05).

• Assessment of skin calming effect after UV irradiation with 22 participants with readings at 24 and 48 hours using Tewameter, Antera 3D and Chroma Meter (statistically significant, p<0.05).

• Assessment of skin calming effect after chemical-induced irritation with 22 participants with readings at 24 and 48 hours using Tewameter, Antera 3D and Chroma Meter (statistically significant, p<0.05).

• Assessment of skin calming effect after physical stimulation with 21 participants with readings at 24 and 48 hours using Tewameter, Antera 3D and Chroma Meter (statistically significant, p<0.05).

• 4-week trans-epidermal water loss study of 21 participants with readings at baseline, 2 and 4 weeks using Tewameter (statistically significant, p<0.05).

• 4-week moisture content in the lower layer of stratum corneum improvement study of 21 participants with readings at baseline, 2 and 4 weeks using Moisture Meter EpiD (statistically significant, p<0.05).

• 4-week consumer perception study of 21 participants with self assessment at week 4.

• 8-week dark circle study of 22 participants with readings at baseline, 4 and 8 weeks using Mexameter MX18 and VISIA-CR (statistically significant, p<0.05).

• 8-week anti-wrinkle study of 22 participants with readings at baseline, 4 and 8 weeks using Antera 3D CS (statistically significant, p<0.05).

• 8-week eye bags study of 22 participants with readings at baseline, 4 and 8 weeks using Antera 3D CS (statistically significant, p<0.05).

• 8-week skin elasticity study of 22 participants with readings at baseline, 4 and 8 weeks using Cutometer MPA580 (statistically significant, p<0.05).

• 8-week consumer perception study of 22 participants with self assessment at week 8.

• 24-hour hydration study of 25 participants with readings at baseline, 1, 3, 6 and 24 hours using Corneometer (statistically significant, p<0.001).

• 42-day hydration study of 50 participants over a 42-day period with readings at baseline, 7, 14, 28 and 42 days using MoistureMeterSC (statistically significant, p<0.001).

• 42-day moisturization study of 50 participants over a 42-day period with readings at baseline, 7, 14, 28 and 42 days using VapoMeter (statistically significant, p<0.005).

• 42-day skin firmness study of 50 participants over a 42-day period with readings at baseline, 7, 14, 28 and 42 days using Cutometer (statistically significant, p<0.001).

• 56-day skin firmness study (double-blinded) of 26 participants over a 56-day period with readings at baseline, 14, 28 and 56 days using Cutometer (statistically significant, p<0.001).

• 42-day skin elasticity study of 50 participants over a 42-day period with readings at baseline, 7, 14, 28 and 42 days using Cutometer (statistically significant, p<0.001).

• 56-day skin elasticity study (double-blinded) of 26 participants over a 56-day period with readings at baseline, 14, 28 and 56 days using Cutometer (statistically significant, p<0.001).

• 42-day anti-wrinkle study of 50 participants over a 42-day period with readings at baseline, 7, 14, 28 and 42 days using PRIMOS 3D (statistically significant, p<0.001).

• 56-day anti-wrinkle study (double-blinded) of 26 participants over a 56-day period with readings at baseline, 14, 28 and 56 days using PRIMOS High Resolution (statistically significant, p<0.05).

• 56-day anti-neck-wrinkle study (double-blinded) of 26 participants over a 56-day period with readings at baseline, 14, 28 and 56 days using PRIMOS Lite (statistically significant, p<0.05).

• 42-day skin smoothness and softness study of 50 participants over a 42-day period with readings at baseline, 7, 14, 28 and 42 days using PRIMOS 3D (statistically significant, p<0.002).

• 56-day skin smoothness study (double-blinded) of 26 participants over a 56-day period with readings at baseline, 14, 28 and 56 days using Frictiometer (statistically significant, p<0.05).

• 28-day skin brightness study of 27 participants over a 28-day period with readings at baseline, 14 and 28 days using Chromameter (statistically significant, p<0.01).

• 28-day skin tone homogeneity study of 27 participants over a 28-day period with readings at baseline, 14 and 28 days using VISIA-CR (statistically significant, p<0.001).

• The proprietary formulation of key bioactives in Age-Reversing All-In-One Concentrate is clinically tested to increase collagen and elastin synthesis (6 weeks / in vitro study using human dermal fibroblast).

• 24-hour consumer perception study of 25 participants with self-assessment on skin smoothness and hydration at 24 hours.

• 28-day consumer perception study of 27 participants over a 28 day period with self-assessment of skin dullness, brightness, and skin tone uniformity at 28 days.

• 28-day consumer perception study of 26 participants over a 28 day period with self-assessment of skin elasticity at 28 days.

• 42-day consumer perception study of 50 participants over a 42 day period with self-assessment of skin health and firmness at 42 days.

• 24-hour hydration study of 25 participants with readings at baseline, 4, 8 and 24 hours using Corneometer (statistically significant, p<0.001).

• Immediate skin radiance study of 26 participants using Glossymeter (statistically significant, p<0.001).

• 28-day anti-wrinkle study of 26 participants over a 28-day period with readings at baseline, 14 and 28 days using ANTERA 3D (statistically significant, p<0.001).

• 28-day skin elasticity study of 26 participants over a 28-day period with readings at baseline, 14 and 28 days using Cutometer (statistically significant, p<0.001).

• 28-day skin firmness study of 26 participants over a 28-day period with readings at baseline, 14 and 28 days using Ultrasound (statistically significant, p<0.001).

• 28-day skin brightening study of 26 participants over a 28-day period with readings at baseline, 14 and 28 days using Chromameter (statistically significant, p<0.001).

• 28-day skin melanin distribution uniformity study of 26 participants over a 28-day period with readings at baseline, 14 and 28 days using ANTERA 3D (statistically significant, p<0.001).

• 28-day skin smoothness study of 26 participants over a 28-day period with readings at baseline, 14 and 28 days using Visioscan (statistically significant, p<0.001).

• 28-day consumer perception study of 26 participants over a 28 day period with self-assessment at 28 days.

• 24-hour hydration study of 25 participants with readings at baseline, 4, 8 and 24 hours using Corneometer (statistically significant, p<0.001).

• Immediate skin radiance study of 25 participants using Glossymeter (statistically significant, p<0.001).

• 28-day skin elasticity study of 25 participants over a 28-day period with readings at baseline, 14 and 28 days using Cutometer (statistically significant, p<0.001).

• 28-day skin firmness study of 25 participants over a 28-day period with readings at baseline, 14 and 28 days using Ultrasound (statistically significant, p<0.001).

• 28-day consumer perception study of 25 participants over a 28 day period with self-assessment at 28 days.

• 24-hour hydration study of 25 participants with readings at baseline, 1, 3, 6 and 24 hours using Corneometer (statistically significant, p<0.001).
  

• Immediate facial lifting study of 26 participants using Moire (statistically significant, p<0.05).

• 28-day facial lifting study of 26 participants over a 28-day period with readings at baseline, 14 and 28 days using Moire (statistically significant, p<0.05).

• Immediate skin radiance study of 25 participants using Skin Glossmeter (statistically significant, p<0.001).

• 4-week hydration study of 28 participants with readings at baseline, 2 and 4 weeks using Epsilon E100 (statistically significant, p<0.05).

• 2-week skin firmness study of 28 participants with readings at baseline and week 2 using Cutometer MPA580 (statistically significant, p<0.05).

• 4-week skin sagging study of 28 participants with readings at baseline, 2 and 4 weeks using VECTRA XT (statistically significant, p<0.05).

• 4-week skin roughness study of 28 participants with readings at baseline, 2 and 4 weeks using PRIMOS lite (statistically significant, p<0.05).

• 4-week skin scale study of 28 participants with readings at baseline, 2 and 4 weeks using D-squame disc (statistically significant, p<0.05).

• 4-week consumer perception study of 28 participants over a 4-week period with with self-assessment at week 4.

• Hair particulate matter cleansing efficacy study using Folliscope (statistically significant, p<0.001).

• 28-day scalp elasticity study of 27 participants over a 28-day period with readings at baseline, 14 and 28 days using Cutometer (statistically significant, p<0.001).

• 28-day scalp dead-skin improvement efficacy study of 27 participants over a 28-day period with readings at baseline, 14 and 28 days using Corneofix F20 and Visioscan VC98 (statistically significant, p<0.001).

• 28-day scalp sebum improvement efficacy study of 27 participants over a 28-day period with readings at baseline, 14 and 28 days using Sebumeter (statistically significant, p<0.001).

You will receive a confirmation e-mail with your order number. Please add care@vennskincare.com to your address book to make sure you receive your confirmation e-mail.

Once your order ships from our warehouse, you will receive a confirmation e-mail with a tracking number. Please add care@vennskincare.com to your address book to make sure you receive your confirmation e-mail and tracking information.

Once you have placed your order, our ability to make changes to or cancel your order may be limited. Please contact care@vennskincare.com, and VENN’s customer care team will work with you to try and accommodate changes or cancellations to your order.

If you have selected expedited shipping (serviced by USPS or FedEx) and have placed your order by 11am PT (2pm ET), you can expect your order to arrive in 2-4 business days. If you have selected overnight shipping (serviced by FedEx) and have placed your order by 11am PT (2pm ET), you can expect your order to arrive in 1-2 business days.

Please contact care@vennskincare.com.

Returns are accepted within 30 days of receipt. Items must be returned unopened/unused, with tags, in their original packaging. You can find VENN’s return policy in the Terms of Service.

Your credit or debit card is charged when you place your order, so that it can be prepared for shipping in a timely manner.

We currently offer only U.S. shipping.